Wordt geladen...
AB065. P-36. Debio 1347 in patients with cholangiocarcinoma harboring an FGFR gene alteration: preliminary results
BACKGROUND: Cholangiocarcinoma (CCA), an aggressive epithelial neoplasm of biliary tract, presents limited treatment options and poor overall survival. Aberrant fibroblast growth factor receptor (FGFR) signaling has been implicated in CCA carcinogenesis especially in intrahepatic cholangiocarcinoma...
Bewaard in:
| Gepubliceerd in: | Hepatobiliary Surg Nutr |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6421195/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.AB065 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|